Global Access Strategy Manager

Talentmark are recruiting for a Global Access Strategy Manager to join a global pharmaceutical company on a contract basis initially for 12 months.

This is a hybrid role with 3 days on site in Slough.

Salary:

£40.62 ph PAYE or £55.87 ph via Umbrella

Global Access Strategy Manager Role:

• Accountable for the development, maintenance and timely delivery of core payer evidence and value deliverables.
• Develop and maintain payer evidence and value deliverables.
• Provide evidence-based inputs and drafting support that help translate strategic assumptions, scenarios, access risks and trade-offs.
• Identify payer-relevant evidence gaps and access risks and coordinate with Health Economics and Real World Evidence colleagues to inform evidence generation priorities.
• Provide structured evidence inputs to Health Economics and Real World Evidence leads for inclusion in relevant evidence governance forums.

• Experience in market access related roles within the (bio)pharmaceutical industry or consulting.
• Experience supporting global or asset-level payer evidence or access projects.
• Direct experience supporting affiliates with HTA submissions, payer interactions or local adaptation of global value materials.
• Understanding of payer and HTA decision‑making in at least one major market.
• Hold a relevant degree or have equivalent working experience.

Our client is a is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology now and into the future.

Location:

This role is based at our client’s site in Slough.

Apply:

For more information, or to apply for this Global Access Strategy Manager

please contact the Key Accounts Team on View phone number on ckgroup.co.uk or email View email address on ckgroup.co.uk. Please quote reference 184 695.

It is essential that applicants hold entitlement to work in the UK.

Please note:

This role may be subject to a satisfactory basic Disclosure and Barring Service (DBS) check.